This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Marvell Technology stock today is moving on a mix of data-center demand, strategic bets, and fresh analyst optimism. ...
Institutional holders control roughly 87% of Starbucks' float, and analysts expect further upside as comps improve an...
The auto parts sector posted a strong year with a 42% rally, but a prominent investor pulled the trigger on a multi-m...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
As the S&P 500 sits near record highs, leadership is shifting toward defensive names. This article explains why consu...
Bitcoin rose back toward the mid-60s, fueled by renewed risk appetite and easing inflation signals. This crypto price...
CrossCountry Mortgage will acquire Summit Funding, a move that broadens its geographic reach and scales its lending p...
A crypto once riding high can crash hard. This guide lays out a practical plan to decide if you should hold, trim, or...
June data showed payroll gains stalled while prime-age participation fell, signaling hidden weakness beneath the surf...